Study on Mitochondrial ATPase6 Gene Polymorphisms as a Genetic Risk Factor for Breast Cancer in Bangladeshi Women

Touhidul Islam, Mohammad and Nahar Sultana, Gazi Nurun and Khan, Robin and Islam, Ariful and Mahmud, Hasan and Zahir Raihan, Sheikh (2021) Study on Mitochondrial ATPase6 Gene Polymorphisms as a Genetic Risk Factor for Breast Cancer in Bangladeshi Women. International Journal of Scientific Research in Dental and Medical Sciences, 3 (1). pp. 18-22.

[thumbnail of IJSRDMS_Volume 3_Issue 1_Pages 18-22.pdf] Text
IJSRDMS_Volume 3_Issue 1_Pages 18-22.pdf - Published Version

Download (423kB)

Abstract

Background and aim: Mitochondria play a vital role in cellular energy production and apoptosis; thus, it has a critical role in cancer development. This study aimed to evaluate polymorphisms in the mitochondrial ATPase6 gene as a genetic risk factor for breast cancer in Bangladeshi women.
Materials and method: ATPase6 gene of mtDNA from sixteen breast cancer blood samples were sequenced to evaluate polymorphisms in the targeted gene. Polymorphisms are detected by comparing the sequences with the Revised Cambridge Reference Sequence (rCRS). Twelve blood samples from age-matched healthy women were also sequenced as a control to consider regional variations.
Results: The A8812C polymorphism (p= 0.0085; from Fisher Exact Test) was found in 50% of breast cancer patients. The A8812C variation (novel mutation) substitutes the Threonine (T) to Proline (P) at the 96th codon number. The PolyPhen-2 analysis predicted that, with a score of 0.999, this variant is "probably damaging." The second prediction performed by the PROVEAN program showed that, since it has a score of -5,110 (<-2,5), this substitution is "Deleterious." These data indicate that A8812C might be associated with an increased risk of breast cancer indirectly. Another interesting finding is the frequent presence (56%) of A8701G in cancer patients (p= 0.0159; from Fisher Exact Test). Based on the statistical data, this (A8701G) mutation might relate to breast cancer development.

Conclusion: It can be concluded that mutations in the ATPase6 gene, especially the A8812C polymorphism and A8701G polymorphism, can be biomarkers for breast cancer diagnosis.

Item Type: Article
Subjects: Open Research Librarians > Medical Science
Depositing User: Unnamed user with email support@open.researchlibrarians.com
Date Deposited: 28 Jan 2023 09:41
Last Modified: 02 Oct 2023 12:45
URI: http://stm.e4journal.com/id/eprint/36

Actions (login required)

View Item
View Item